Safety Study of Pyridostigmine in Heart Failure (APP-HF)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Nathan Kline Institute for Psychiatric Research
Oklahoma State University
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Stuart Katz, New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT01415921
First received: August 10, 2011
Last updated: October 8, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2016
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)